Benzimidazole derivatives as modulators of IgE
US6303645A · kind A · utility
8Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 21, 1999 |
| Grant date | Oct 16, 2001 |
| Priority date | — |
| Expiry date | Oct 21, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a family of diacyl benzimidazole analogs, which are inhibitors of the IgE response to allergens. These compounds are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.